SLC26A3-IN-2 is an orally active inhibitor of the anion exchanger protein SLC26A3 (IC50 = 360 nM); it is used to study the role of SLC26A3 in intestinal chloride and oxalate absorption and its association with chloride-losing diarrhea caused by loss-of-function mutations.